norfloxacin has been researched along with rufloxacin in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cecchetti, V; Fravolini, A; Fringuelli, R; Mascellani, G; Pagella, P; Palmioli, M; Segre, G; Terni, P | 1 |
| Carrupt, PA; Crivori, P; Cruciani, G; Testa, B | 1 |
| Aguilar, L; Giménez, MJ; Jiménez de Anta, MT; Marco, F; Marcos, MA; Salvá, P | 1 |
| Aguilar, L; Fernández-Roblas, R; García-Corbeira, P; López, JC; Soriano, F | 1 |
| Aguilar, L; Balcabao, IP; Costa, J; Dal-ré, R; Martín, M; Prieto, J; Salvá, P | 1 |
| Aguilar, L; Caffaratti, J; Dal-Ré, R; Dalet, F; Del Río, G | 1 |
| Aguilar, L; Costa, J; Dal-Ré, R; Giménez, MJ; Prieto, J | 1 |
| Bauer, TM; Bory, F; Clemente, G; Follo, A; Navasa, M; Planas, R; Rodés, J; Vaquer, P; Vargas, V; Vila, J | 1 |
| Andreeva, I; Rafalsky, V; Rjabkova, E | 1 |
1 review(s) available for norfloxacin and rufloxacin
| Article | Year |
|---|---|
Quinolones for uncomplicated acute cystitis in women.
Topics: Acute Disease; Adult; Anti-Infective Agents, Urinary; Ciprofloxacin; Cystitis; Female; Fluoroquinolones; Humans; Levofloxacin; Norfloxacin; Ofloxacin; Pefloxacin; Quinolones; Randomized Controlled Trials as Topic | 2006 |
5 trial(s) available for norfloxacin and rufloxacin
| Article | Year |
|---|---|
Comparison of rufloxacin and norfloxacin effects on faecal flora.
Topics: Adult; Anti-Infective Agents; Bacteroides fragilis; Colony Count, Microbial; Escherichia coli; Feces; Fluoroquinolones; Humans; Male; Norfloxacin; Quinolones | 1995 |
Ex vivo antibacterial properties of rufloxacin compared with those of norfloxacin in a study with healthy volunteers.
Topics: Adult; Anti-Infective Agents; Bacteriuria; Cross-Over Studies; Escherichia coli Infections; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Norfloxacin; Quinolones; Serum Bactericidal Test; Staphylococcal Infections | 1996 |
Single-dose rufloxacin versus 3-day norfloxacin treatment of uncomplicated cystitis: clinical evaluation and pharmacodynamic considerations.
Topics: Adult; Anti-Infective Agents; Cystitis; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Middle Aged; Norfloxacin; Quinolones; Recurrence | 1996 |
Suspicion of quinolone active metabolite following discrepancy between predicted and experimental urine bactericidal activities.
Topics: Anti-Infective Agents; Area Under Curve; Escherichia coli; Fluoroquinolones; Humans; Norfloxacin; Predictive Value of Tests; Quinolones; Staphylococcus aureus | 1997 |
Daily norfloxacin is more effective than weekly rufloxacin in prevention of spontaneous bacterial peritonitis recurrence.
Topics: Aged; Anti-Infective Agents; Female; Fluoroquinolones; Humans; Liver Cirrhosis; Male; Middle Aged; Norfloxacin; Peritonitis; Prospective Studies; Quinolones; Secondary Prevention; Treatment Outcome | 2002 |
3 other study(ies) available for norfloxacin and rufloxacin
| Article | Year |
|---|---|
Quinolonecarboxylic acids. 2. Synthesis and antibacterial evaluation of 7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzothiazine-6-carboxylic acids.
Topics: Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Gram-Negative Bacteria; Gram-Positive Bacteria; Indicators and Reagents; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Pyridones; Spectrophotometry, Infrared; Thiazines | 1987 |
Predicting blood-brain barrier permeation from three-dimensional molecular structure.
Topics: Blood-Brain Barrier; Databases, Factual; Models, Chemical; Molecular Conformation; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Comparative in-vitro activity of rufloxacin with five other antimicrobial agents against bacterial enteric pathogens.
Topics: Ampicillin; Anti-Infective Agents; Campylobacter jejuni; Colistin; Digestive System; Doxycycline; Enterobacteriaceae; Escherichia coli; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Norfloxacin; Quinolones; Trimethoprim, Sulfamethoxazole Drug Combination; Vibrionaceae | 1994 |